Business News

Regulations gripping UBS

UBS, one of Switzerland’s largest banks, is poised to face stricter regulations in the wake of the Swiss government’s response to the rescue of Credit Suisse. The move comes as authorities seek to bolster oversight of the country’s financial sector following the high-profile troubles experienced by Credit Suisse. In an article published by Reuters on […]

Regulations gripping UBS Read More »

Apple doubles India iPhone production to $14 billion as it shifts from China: Report

Apple produced $14 billion worth of iPhones in India over the last fiscal year, a sign of the company’s continued effort to manufacture more devices outside of China, a report from Bloomberg said Wednesday. As relations between the U.S. and China have soured, Apple has worked to diversify its supply chain by expanding production in countries like Vietnam and India. It’s

Apple doubles India iPhone production to $14 billion as it shifts from China: Report Read More »

Whats so concerning from the UK Inflation Data numbers

Britain remains on course to have the highest inflation of leading rich economies in 2023, according to Organisation for Economic Co-operation and Development forecasts which showed the country\’s inflation problem widening compared with most of its peers. Britain\’s headline inflation rate was set to average 7.2% over 2023, up from a previous forecast of 6.9%

Whats so concerning from the UK Inflation Data numbers Read More »

OTC Markets Group Welcomes Khiron Life Sciences Corp. to OTCQX

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Khiron Life Sciences Corp (TSX-V: KHRN;OTCQX: KHRNF), a vertically integrated cannabis leader with core operations in Latin America, has qualified to trade on the OTCQX® Best Market. Khiron Life Sciences Corp. upgraded to OTCQX from the OTCQB®

OTC Markets Group Welcomes Khiron Life Sciences Corp. to OTCQX Read More »

SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia

SutroVax, a biopharmaceutical company dedicated to the delivery of superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide, today announced the closing of a $110 million Series D preferred stock financing, co-led by new investors RA Capital Management and Janus Henderson Investors. All of SutroVax\\\’s

SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia Read More »

Scroll to Top